Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386030063> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W4386030063 endingPage "12988" @default.
- W4386030063 startingPage "12988" @default.
- W4386030063 abstract "Metastatic disease is linked to TERT promoter mutations in conjunctival melanomas (CM). Both TERT promoter and ATRX mutations are associated with faulty telomere maintenance. This study aimed to determine the prognostic value of ATRX loss in conjunctival melanocytic lesions. Eighty-six conjunctival melanocytic lesions from the Rotterdam Ocular Melanoma Study group were collected. ATRX status and TERT promoter status were determined using immunohistochemical staining and molecular diagnostics, respectively. None of the nevi (n = 16) and primary acquired melanosis (PAM) without atypia (n = 6) showed ATRX loss. ATRX loss was found in 2/5 PAM with atypia without CM and in 8/59 CM. No cases with a TERT promoter mutation (n = 26) showed ATRX loss. Eight/eleven metastatic CM harbored a TERT promoter mutation, two other metastatic CM showed ATRX loss and one metastatic case showed no TERT promoter/ATRX alterations. In conclusion ATRX loss and TERT promoter mutations are only found in (pre)malignant conjunctival melanocytic lesions, with most metastatic cases harboring one of these alterations, suggesting that both alterations are associated with adverse behavior. Similar to TERT promoter mutations, ATRX loss may be used as a diagnostic tool in determining whether a conjunctival melanocytic lesion is prone to having an adverse course." @default.
- W4386030063 created "2023-08-22" @default.
- W4386030063 creator A5000445750 @default.
- W4386030063 creator A5031905985 @default.
- W4386030063 creator A5040057938 @default.
- W4386030063 creator A5048607719 @default.
- W4386030063 creator A5050211198 @default.
- W4386030063 creator A5058109283 @default.
- W4386030063 creator A5071455253 @default.
- W4386030063 date "2023-08-20" @default.
- W4386030063 modified "2023-09-29" @default.
- W4386030063 title "ATRX Loss in the Development and Prognosis of Conjunctival Melanoma" @default.
- W4386030063 cites W1950829641 @default.
- W4386030063 cites W2057308377 @default.
- W4386030063 cites W2058321871 @default.
- W4386030063 cites W2097563467 @default.
- W4386030063 cites W2131967786 @default.
- W4386030063 cites W2270952161 @default.
- W4386030063 cites W2581179619 @default.
- W4386030063 cites W2611187032 @default.
- W4386030063 cites W2738766141 @default.
- W4386030063 cites W2803887413 @default.
- W4386030063 cites W2959999666 @default.
- W4386030063 cites W2960092050 @default.
- W4386030063 cites W3000360238 @default.
- W4386030063 cites W3014066822 @default.
- W4386030063 cites W3046045055 @default.
- W4386030063 cites W3081775046 @default.
- W4386030063 cites W3092206515 @default.
- W4386030063 cites W3094744928 @default.
- W4386030063 cites W3160388452 @default.
- W4386030063 cites W3164963267 @default.
- W4386030063 cites W4206994747 @default.
- W4386030063 cites W4213054758 @default.
- W4386030063 cites W4220662688 @default.
- W4386030063 cites W4306732880 @default.
- W4386030063 cites W4323350619 @default.
- W4386030063 cites W4324092569 @default.
- W4386030063 cites W571060166 @default.
- W4386030063 doi "https://doi.org/10.3390/ijms241612988" @default.
- W4386030063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37629169" @default.
- W4386030063 hasPublicationYear "2023" @default.
- W4386030063 type Work @default.
- W4386030063 citedByCount "0" @default.
- W4386030063 crossrefType "journal-article" @default.
- W4386030063 hasAuthorship W4386030063A5000445750 @default.
- W4386030063 hasAuthorship W4386030063A5031905985 @default.
- W4386030063 hasAuthorship W4386030063A5040057938 @default.
- W4386030063 hasAuthorship W4386030063A5048607719 @default.
- W4386030063 hasAuthorship W4386030063A5050211198 @default.
- W4386030063 hasAuthorship W4386030063A5058109283 @default.
- W4386030063 hasAuthorship W4386030063A5071455253 @default.
- W4386030063 hasBestOaLocation W43860300631 @default.
- W4386030063 hasConcept C104317684 @default.
- W4386030063 hasConcept C142724271 @default.
- W4386030063 hasConcept C2776689207 @default.
- W4386030063 hasConcept C2777658100 @default.
- W4386030063 hasConcept C2781283455 @default.
- W4386030063 hasConcept C501734568 @default.
- W4386030063 hasConcept C502942594 @default.
- W4386030063 hasConcept C54355233 @default.
- W4386030063 hasConcept C71924100 @default.
- W4386030063 hasConcept C86803240 @default.
- W4386030063 hasConceptScore W4386030063C104317684 @default.
- W4386030063 hasConceptScore W4386030063C142724271 @default.
- W4386030063 hasConceptScore W4386030063C2776689207 @default.
- W4386030063 hasConceptScore W4386030063C2777658100 @default.
- W4386030063 hasConceptScore W4386030063C2781283455 @default.
- W4386030063 hasConceptScore W4386030063C501734568 @default.
- W4386030063 hasConceptScore W4386030063C502942594 @default.
- W4386030063 hasConceptScore W4386030063C54355233 @default.
- W4386030063 hasConceptScore W4386030063C71924100 @default.
- W4386030063 hasConceptScore W4386030063C86803240 @default.
- W4386030063 hasIssue "16" @default.
- W4386030063 hasLocation W43860300631 @default.
- W4386030063 hasLocation W43860300632 @default.
- W4386030063 hasOpenAccess W4386030063 @default.
- W4386030063 hasPrimaryLocation W43860300631 @default.
- W4386030063 hasRelatedWork W1998732460 @default.
- W4386030063 hasRelatedWork W2021968456 @default.
- W4386030063 hasRelatedWork W2050957808 @default.
- W4386030063 hasRelatedWork W2068861579 @default.
- W4386030063 hasRelatedWork W2344529329 @default.
- W4386030063 hasRelatedWork W2412245334 @default.
- W4386030063 hasRelatedWork W2790628335 @default.
- W4386030063 hasRelatedWork W2904787599 @default.
- W4386030063 hasRelatedWork W2981372661 @default.
- W4386030063 hasRelatedWork W3211787047 @default.
- W4386030063 hasVolume "24" @default.
- W4386030063 isParatext "false" @default.
- W4386030063 isRetracted "false" @default.
- W4386030063 workType "article" @default.